Published on Novartis Australia (https://www.novartis.com.au)
Home > Printer-friendly PDF > Our Business
Our Business
[1]
Novartis focuses its business on three divisions with innovation power and global scale:
pharmaceuticals, eye care and generics. These three divisions are supported by our research
organization, the Novartis Institutes for BioMedical Research (NIBR) [2], and a centralized
services group, Novartis Business Services, to facilitate collaboration across our divisions,
and drive efficiency and productivity gains.
We aim to develop innovative products in growing areas of healthcare. At the same time, we
are expanding our presence in the emerging markets of Asia, Africa and Latin America, where
there is fast-growing demand for access to high-quality medicines and healthcare.
Pharmaceuticals
Pharmaceuticals develops innovative, patent-protected medicines to enhance health
outcomes for patients and health-care providers. The division is at the forefront of
development and commercialization in oncology, primary care and specialty medicines.
Read More [3]
Alcon (Eye Care)
Alcon provides innovative products that enhance quality of life by helping people worldwide
see better. Its three businesses – Surgical, Ophthalmic Pharmaceuticals and Vision Care –
offer the world's widest spectrum of eye care products.
Read More [4]
Sandoz (Generics)
Sandoz is a global leader in the rapidly growing generics industry. Its products – which are
focused in Retail Generics, Biopharmaceuticals & Oncology Injectables, and Anti-Infectives –
help make affordable, high-quality medicines available to more people.
Read More [5]
Source URL: https://www.novartis.com.au/about-us/our-business
Links
[1] https://www.novartis.com.au/about-us/our-business
[2] http://www.nibr.com/
[3] http://www.novartispharmaceuticals.com/en
[4] https://www.alcon.com/
[5] http://www.sandoz.com/